Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Frontiers in Oncology|April 1, 2026
Ultrasound-based deep learning radiomics for the differential diagnosis of benign and malignant subpleural pulmonary lesionsLiyan Wei, Jingtong Zeng, Yi Feng, et al.Frontiers in Immunology|October 21, 2024
Oncolytic virotherapy against lung cancer: key receptors and signaling pathways of viral entryWenxun Dong, Ying Luo, Daqian He, et al.Cancers|September 28, 2023
A Review of Biomarkers and Their Clinical Impact in Resected Early-Stage Non-Small-Cell Lung CancerWeibo Cao, Quanying Tang, Jingtong Zeng, et al.Discover Oncology|August 13, 2025
Comorbidity of hypertension and lung cancer: interplay of genetics and environmentJingtong Zeng, Difang Shi, Daqian He, et al.ACS Applied Materials & Interfaces|September 22, 2025
A Phototherapy Nanosensitizer-Unlocked Multihit Strategy to Inhibit Tumor Stemness and Potentiate Sorafenib Response in Hepatocellular CarcinomaTian Qin, Huaze Lu, Qin Wang, et al.BMC Cancer|June 25, 2026
Habitat model based on CEUS for noninvasive prediction of EGFR mutation status in peripheral NSCLCJingtong Zeng, Liyan Wei, Hengfei Chen, et al.Respiratory Research|February 10, 2026
Unique clinical features and transcriptomic profiling of carcinogenesis in patients with familial lung cancer in Yunnan Province, Wumeng mountains, ChinaJingtong Zeng, Hongli Lin, Difang Shi, et al.Journal of Clinical Medicine|November 11, 2022
The Profile and Clinical Significance of ITGB2 Expression in Non-Small-Cell Lung CancerLingling Zu, Jinling He, Ning Zhou, et al.Frontiers in Oncology|September 30, 2022
Use of savolitinib as neoadjuvant therapy for non-small cell lung cancer patient with MET exon 14 skipping alterations: A case reportYu Zhang, Hao Zhang, Hanqing Wang, et al.Frontiers in Oncology|March 12, 2025
Ensartinib as a neoadjuvant therapy for stage IIIA non-small cell lung cancer patients with EML4-ALK fusion: a case report and literature reviewHao Zhang, Wei Xia, Yifan Zhang, et al.Pageof 2